Humira

adalimumab · AbbVie Deutschland GmbH & Co. KG
AUTHORISED IN THE EU

What Humira is used for

Please refer to the product information document.

Approved use, as published by the European Medicines Agency.

Key facts

Brand
Humira
Active substance
adalimumab
Disease area
Spondylitis, Ankylosing; Arthritis, Juvenile Rheumatoid; Uveitis; Colitis, Ulcerative; Psoriasis; Arthritis, Psoriatic; Crohn Disease; Arthritis, Rheumatoid
Medicine group
Immunosuppressants
ATC code
L04AB04
Marketing authorisation holder
AbbVie Deutschland GmbH & Co. KG
Authorised in the EU since
2003

Official information

In the USA

Same active substance: Amjevita, Hyrimoz, Humira, Hadlima, Yusimry

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Humira used for?

Please refer to the product information document.

What is the active substance in Humira?

Humira contains adalimumab.

Who makes Humira?

The EU marketing authorisation holder is AbbVie Deutschland GmbH & Co. KG.

Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.

← All specialty medicines, EU

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.